At BenevolentAI, your privacy and trust are important to us. We use cookies to personalise content, provide social media features and to analyse our websites for better performance. Information about your use of our website may be shared with our social media and analytics partners from time to time. Detailed understanding of cookies and how to control their placement on your system can be found in our Privacy Policy
Got It
At BenevolentAI, your privacy and trust are important to us. We use cookies to personalise content, provide social media features and to analyse our websites for better performance. Information about your use of our website may be shared with our social media and analytics partners from time to time. Detailed understanding of cookies and how to control their placement on your system can be found in our Privacy Policy
Got It

Human life is precious.
We have never been more aware of its fragility.

Today there are thousands of diseases that have no treatment and
millions are suffering with no hope for a cure. Patients deserve better.

WHAT WE DO

We envision a world where no disease goes untreated.

This is not a world that will emerge, it is a world we must create. The exponential growth and availability of biomedical data present new opportunities to fuse science and technology and re-engineer drug discovery and development. This is what we do.

OUR MISSION

Decoding disease to understand its underlying causes.

Every day there are thousands of scientific papers published, hundreds of millions of medical records created, vast amounts of data collected and research completed. Our AI and machine learning models empower scientists to make sense of all of that information to decipher the complex code underlying human biology.

what we do

Our work to decode COVID-19.

Responding to the global health crisis, we turned our AI platform toward identifying existing drugs that could be used to treat the novel coronavirus. Our research led to a clinical trial with Eli Lilly and the US National Institute for Allergies and Infectious Diseases.

find out more

We envision a world where no disease goes untreated

This is not a world that will emerge, it is a world we must create. The exponential growth and availability of biomedical data present new opportunities to fuse science and technology and re-engineer drug discovery and development. This is what we do.

We decode disease to understand its underlying causes

Every day there are thousands of scientific papers published, hundreds of millions of medical records created, vast amounts of data collected and research completed. Our machine learning models and algorithms empower scientists to make sense of all of that information.

Our research to find a potential treatment for COVID-19

Responding to the global health crisis, we turned our AI platform toward identifying existing drugs that could be used to treat the novel coronavirus. Our research led to a clinical trial with Eli Lilly and the US National Institute for Allergies and Infectious Diseases.
BEcause it matters.

The Benevolent Platform®

Human intelligence and technology united to re-engineer drug discovery and deliver life-changing medicines.

Knowledge & Reasoning

Our expanding biomedical knowledge base of contextualised machine-curated relationships and proprietary insights represents what is known and can be inferred about a disease.

Target Identification

Data-driven Target ID built on our machine learning models selects and validates the highest quality, hypotheses for novel drug targets.

Precision Medicine

Applied machine learning models enable scientists to determine the right mechanism to modulate, and identify patient endotypes more likely to respond to treatment.

Molecular Design

AI-augmented models empower our chemists to evaluate millions of molecular structures, generate drug-like molecules and design better drugs in fewer cycles.

WHAT WE DO

Join forces with us

By working together, profound discoveries are made

Partner with us
Our Benevolent people

Mission-driven to preserve human life

At Benevolent we build technology in the service of science -  to augment human intelligence and inspire the discovery of new medicines for the thousands of diseases that have no treatment.

01
ABOUT US
02
PURPOSE
03
Join us

"The fragile nature of life and health has never been more apparent, but the partnership of human and artificial intelligence promises to accelerate new discoveries, new therapies and new hope for patients."

Joanna Shields  —  CEO, BenevolentAI
What we doAbout uscareersCOVID-19Data Diversity initiative
Contact us
Company Registration: 09781806
Terms & Conditions
Privacy & Cookies Policy